Canada markets closed

Barinthus Biotherapeutics plc (2AB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.9200-0.0300 (-1.54%)
At close: 08:06AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 77.90M
Enterprise Value -42.57M
Trailing P/E 8.42
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)100.03
Price/Book (mrq)0.44
Enterprise Value/Revenue -53.08
Enterprise Value/EBITDA 0.60

Trading Information

Stock Price History

Beta (5Y Monthly) -0.51
52-Week Change 3-2.01%
S&P500 52-Week Change 322.38%
52 Week High 34.4400
52 Week Low 31.5000
50-Day Moving Average 32.3794
200-Day Moving Average 32.5041

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 538.92M
Implied Shares Outstanding 641.19M
Float 818.37M
% Held by Insiders 13.69%
% Held by Institutions 147.85%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-10,024.69%

Management Effectiveness

Return on Assets (ttm)-20.73%
Return on Equity (ttm)-34.15%

Income Statement

Revenue (ttm)802k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -78.17M
Net Income Avi to Common (ttm)-73.35M
Diluted EPS (ttm)-1.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)142.09M
Total Cash Per Share (mrq)3.65
Total Debt (mrq)12.98M
Total Debt/Equity (mrq)6.94%
Current Ratio (mrq)12.45
Book Value Per Share (mrq)4.83

Cash Flow Statement

Operating Cash Flow (ttm)-50.92M
Levered Free Cash Flow (ttm)-42.35M